A cascade leading to premature aging phenotypes including abnormal tumor profiles in Werner syndrome (Review)
- Authors:
- Masanobu Sugimoto
-
Affiliations: GeneCare Research Institute, Co. Ltd., Kamakura, Kanagawa 247-0063, Japan - Published online on: December 17, 2013 https://doi.org/10.3892/ijmm.2013.1592
- Pages: 247-253
This article is mentioned in:
Abstract
 |
 |
 |
|
Goto M and Miller R: From Premature Gray Hair to Helicase - Werner Syndrome: Implications for Aging and Cancer. Gann Monograph on Cancer Research No 49. Japan Scientific Societies Press & Karger; Tokyo: 2001 | |
|
Nishimura F, Arakawa M and Goto M: Letter to the editor: periodontal conditions in Werner syndrome. J Periodontol. 81:32010. View Article : Google Scholar : PubMed/NCBI | |
|
Goto M, Rubenstein M, Weber J, Woods K and Drayna D: Genetic linkage of Werner’s syndrome to five markers on chromosome 8. Nature. 355:735–738. 1992. | |
|
Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J and Schellenberg GD: Positional cloning of the Werner’s syndrome gene. Science. 272:258–262. 1996. | |
|
Suzuki N, Shimamoto A, Imamura O, Kuromitsu J, Kitao S, Goto M and Furuichi Y: DNA helicase activity in Werner’s syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res. 25:2973–2978. 1997. | |
|
Suzuki N, Shiratori M, Goto M and Furuichi Y: Werner syndrome helicase contains a 5′→3′ exonuclease activity that digests DNA and RNA strands in DNA/DNA and RNA/DNA duplexes dependent on unwinding. Nucleic Acids Res. 27:2361–2368. 1999. | |
|
Huang S, Li B, Gray MD, Oshima J, Mian IS and Campisi J: The premature ageing syndrome protein, WRN, is a 3′→5′ exonuclease. Nat Genet. 20:114–116. 1998. | |
|
Seki M, Miyazawa H, Tada S, Yanagisawa J, Yamaoka T, Hoshino S, Ozawa K, Eki T, Nogami M and Okumura K: Molecular cloning of cDNA encoding human DNA helicase Q1 which has homology to Escherichia coli Rec Q helicase and localization of the gene at chromosome 12p12. Nucleic Acids Res. 22:4566–4573. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, Proytcheva M and German J: The Bloom’s syndrome gene product is homologous to RecQ helicases. Cell. 83:655–666. 1995. | |
|
Kitao S, Shimamoto A, Goto M, Miller RW, Smithson WA, Lindor NM and Furuichi Y: Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat Genet. 22:82–84. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Shimamoto A, Nishikawa K, Kitao S and Furuichi Y: Human RecQ5beta, a large isomer of RecQ5 DNA helicase, localizes in the nucleoplasm and interacts with topoisomerases 3alpha and 3beta. Nucleic Acids Res. 28:1647–1655. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shimamoto A, Sugimoto M and Furuichi Y: Molecular biology of Werner syndrome. Int J Clin Oncol. 9:288–298. 2004. View Article : Google Scholar | |
|
Bohr VA: Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance. Trends Biochem Sci. 33:609–620. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Goto M: Syndrome-causing mutations in Werner syndrome. Biosci Trends. 2:147–150. 2008. | |
|
Goto M, Imamura O, Kuromitsu J, Matsumoto T, Yamabe Y, Tokutake Y, Suzuki N, Mason B, Drayna D, Sugawara M, Sugimoto M and Furuichi Y: Analysis of helicase gene mutations in Japanese Werner’s syndrome patients. Hum Genet. 99:191–193. 1997. | |
|
Goto M, Yamabe M, Shiratori M, Okada M, Kawabe T, Matsumoto T, Sugimoto M and Furuichi Y: Immunological diagnosis of Werner syndrome by down-regulated and truncated gene products. Hum Genet. 105:301–307. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Matsumoto T, Shimamoto A, Goto M and Furuichi Y: Impaired nuclear localization of defective DNA helicases in Werner’s syndrome. Nat Genet. 16:335–336. 1997.PubMed/NCBI | |
|
Matsumoto T, Imamura O, Goto M and Furuichi Y: Characterization of the nuclear localization signal in the DNA helicase involved in Werner’s syndrome. Int J Mol Med. 1:71–76. 1998.PubMed/NCBI | |
|
Salk D, Au K, Hoehn H and Martin GM: Cytogenetics of Werner’s syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenet Cell Genet. 30:92–107. 1981. | |
|
Fukuchi K, Martin GM and Monnat RJ Jr: Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc Natl Acad Sci USA. 86:5893–5897. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Gebhart E, Bauer R, Raub U, Schinzel M, Ruprecht KW and Jonas JB: Spontaneous and induced chromosomal instability in Werner syndrome. Hum Genet. 80:135–139. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Schulz VP, Zakian VA, Ogburn CE, McKay J, Jarzebowicz AA, Edland SD and Martin GM: Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet. 97:750–754. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Ishikawa N, Nakamura K, Izumiyama-Shimomura N, Aida J, Ishii A, Goto M, Ishikawa Y, Asaka R, Matsuura M, Hatamochi A, Kuroiwa M and Takubo K: Accelerated in vivo epidermal telomere loss in Werner syndrome. Aging (Albany NY). 3:417–429. 2011.PubMed/NCBI | |
|
Tahara H, Tokutake Y, Maeda S, Kataoka H, Watanabe T, Satoh M, Matsumoto T, Sugawara M, Ide T, Goto M, Furuichi Y and Sugimoto M: Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner’s syndrome patients transformed by Epstein-Barr virus. Oncogene. 15:1911–1920. 1997.PubMed/NCBI | |
|
Counter CM, Botelho FM, Wang P, Harley CB and Bacchetti S: Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol. 68:3410–3414. 1994.PubMed/NCBI | |
|
Sugimoto M, Tahara H, Ide T and Furuichi Y: Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 64:3361–3364. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Sugimoto M, Ide T, Goto M and Furuichi Y: Incorrect use of ‘immortalization’ for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J Virol. 73:9690–9691. 1999. | |
|
Sugimoto M, Ide T, Goto M and Furuichi Y: Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines. Mech Ageing Dev. 107:51–60. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med. 3:1271–1274. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 37:614–636. 1965. View Article : Google Scholar : PubMed/NCBI | |
|
Fry M and Loeb LA: Human werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n. J Biol Chem. 274:12797–12802. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Crabbe L, Verdun RE, Haggblom CI and Karlseder J: Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science. 306:1951–1953. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Crabbe L, Jauch A, Naeger CM, Holtgreve-Grez H and Karlseder J: Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc Natl Acad Sci USA. 104:2205–2210. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Damerla RR, Knickelbein KE, Strutt S, Liu FJ, Wang H and Opresko PL: Werner syndrome protein suppresses the formation of large deletions during the replication of human telomeric sequences. Cell Cycle. 11:3036–3044. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100–2110. 2005.PubMed/NCBI | |
|
Palm W and de Lange T: How shelterin protects mammalian telomeres. Annu Rev Genet. 42:301–334. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Diotti R and Loayza D: Shelterin complex and associated factors at human telomeres. Nucleus. 2:119–135. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ozgenc A and Loeb LA: Current advances in unraveling the function of the Werner syndrome protein. Mutat Res. 577:237–251. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fujiwara Y, Higashikawa T and Tatsumi M: A retarded rate of DNA replication and normal level of DNA repair in Werner’s syndrome fibroblasts in culture. J Cell Physiol. 92:365–374. 1977.PubMed/NCBI | |
|
Hanaoka F, Yamada M, Takeuchi F, Goto M, Miyamoto T and Hori T: Autoradiographic studies of DNA replication in Werner’s syndrome cells. Adv Exp Med Biol. 190:439–457. 1985.PubMed/NCBI | |
|
Poot M, Hoehn H, Runger TM and Martin GM: Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp Cell Res. 202:267–273. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Sahin E and DePinho RA: Axis of ageing: telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol. 13:397–404. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sharpless NE and DePinho RA: Telomeres, stem cells, senescence, and cancer. J Clin Invest. 113:160–168. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Davis T, Faragher RG, Jones CJ and Kipling D: Investigation of the signaling pathways involved in the proliferative life span barriers in werner syndrome fibroblasts. Ann NY Acad Sci. 1019:274–277. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, Lombard D, Pathak S, Guarente L and DePinho RA: Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet. 36:877–882. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Sahin E, Colla S, Liesa M, et al: Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 470:359–365. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Labbe A, Lafleur VN, Patten DA, Robitaille GA, Garand C, Lamalice L, Lebel M and Richard DE: The Werner syndrome gene product (WRN): a repressor of hypoxia-inducible factor-1 activity. Exp Cell Res. 318:1620–1632. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Croteau DL, Rossi ML, Canugovi C, Tian J, Sykora P, Ramamoorthy M, Wang ZM, Singh DK, Akbari M, Kasiviswanathan R, Copeland WC and Bohr VA: RECQL4 localizes to mitochondria and preserves mitochondrial DNA integrity. Aging Cell. 11:456–466. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
De S, Kumari J, Mudgal R, Modi P, Gupta S, Futami K, Goto H, Lindor NM, Furuichi Y, Mohanty D and Sengupta S: RECQL4 is essential for the transport of p53 to mitochondria in normal human cells in the absence of exogenous stress. J Cell Sci. 125(Pt 10): 2509–2522. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pagano G, Zatterale A, Degan P, d’Ischia M, Kelly FJ, Pallardo FV and Kodama S: Multiple involvement of oxidative stress in Werner syndrome phenotype. Biogerontology. 6:233–243. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Pagano G, Zatterale A, Degan P, d’Ischia M, Kelly FJ, Pallardo FV, Calzone R, Castello G, Dunster C, Giudice A, Kilinc Y, Lloret A, Manini P, Masella R, Vuttariello E and Warnau M: In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotes. Free Radic Res. 39:529–533. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Goto M, Takeuchi F, Tanimoto K and Miyamoto T: Clinical, demographic, and genetic aspects of the Werner syndrome in Japan. Werner’s Syndrome and Human Aging. Advances in Experimental Medicine and Biology. 190. Salk D, Fujiwara Y and Martin GM: Plenum Press; New York: pp. 245–261. 1985, PubMed/NCBI | |
|
Takeuchi F, Kamatani N, Goto M, Matsuta K, Nishida Y, Sasaki S, Nishioka K, Mikanagi K, Tanimoto K, Muranaka M and Miyamoto T: Gout-like arthritis in patients with Werner’s syndrome. Jap J Rheumatol. 1:215–220. 1987. | |
|
Massip L, Garand C, Paquet ER, Cogger VC, O’Reilly JN, Tworek L, Hatherell A, Taylor CG, Thorin E, Zahradka P, Le Couteur DG and Lebel M: Vitamin C restores healthy aging in a mouse model for Werner syndrome. FASEB J. 24:158–172. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Goto M: Inflammaging (inflammation + aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends. 2:218–230. 2008. | |
|
Goto M, Sugimoto K, Hayashi S, Ogino T, Sugimoto M, Furuichi Y, Matsuura M, Ishikawa Y, Iwaki-Egawa S and Watanabe Y: Aging-associated inflammation in healthy Japanese individuals and patients with Werner syndrome. Exp Gerontol. 47:936–939. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Davis T, Wyllie FS, Rokicki MJ, Bagley MC and Kipling D: The role of cellular senescence in Werner syndrome: toward therapeutic intervention in human premature aging. Ann NY Acad Sci. 1100:455–469. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Goto M, Iwaki-Egawa S and Watanabe Y: Ageing in Werner syndrome. Biosci Trends. 6:33–37. 2012. | |
|
Kaplan M and Aviram M: Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med. 37:777–787. 1999. View Article : Google Scholar | |
|
Lebel M and Leder P: A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc Natl Acad Sci USA. 95:13097–13102. 1998. View Article : Google Scholar | |
|
Okada M, Goto M, Furuichi Y and Sugimoto M: Differential effects of cytotoxic drugs on mortal and immortalized B- lymphoblastoid cell lines from normal and Werner’s syndrome patients. Biol Pharm Bull. 21:235–239. 1998.PubMed/NCBI | |
|
Futami K, Ishikawa Y, Goto M, Furuichi Y and Sugimoto M: Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Cancer Sci. 99:843–848. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Shiratori M, Suzuki T, Itoh C, Goto M, Furuichi Y and Matsumoto T: WRN helicase accelerates the transcription of ribosomal RNA as a component of an RNA polymerase I-associated complex. Oncogene. 21:2447–2454. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Wullschleger S, Loewith R and Hall MN: TOR signaling in growth and metabolism. Cell. 124:471–484. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Blagosklonny MV and Hall MN: Growth and aging: a common molecular mechanism. Aging (Albany NY). 1:357–362. 2009.PubMed/NCBI | |
|
Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E and Miller RA: Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 460:392–395. 2009.PubMed/NCBI | |
|
Sharp ZD: Aging and TOR: interwoven in the fabric of life. Cell Mol Life Sci. 68:587–597. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Galluzzi L, Kepp O and Kroemer G: TP53 and MTOR crosstalk to regulate cellular senescence. Aging (Albany NY). 2:535–537. 2010.PubMed/NCBI | |
|
Talaei F, van Praag VM and Henning RH: Hydrogen sulfide restores a normal morphological phenotype in Werner syndrome fibroblasts, attenuates oxidative damage and modulates mTOR pathway. Pharmacol Res. 74:34–44. 2013. View Article : Google Scholar | |
|
Goto M, Miller RW, Ishikawa Y and Sugano H: Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev. 5:239–246. 1996.PubMed/NCBI | |
|
Goto M, Ishikawa Y, Sugimoto M and Furuichi Y: Werner syndrome: a changing pattern of clinical manifestations in Japan (1917–2008). Biosci Trends. 7:13–22. 2013.PubMed/NCBI | |
|
Monnat RJ Jr: Cancer pathogenesis in the human RecQ helicase deficiency syndromes. From Premature Gray Hair to Heicase - Werner Syndrome: Implications from Aging and Cancer. Goto M and Miller RW: Basel: pp. 83–94. 2001 | |
|
Sugimoto M, Tahara H, Okubo M, Kobayashi T, Goto M, Ide T and Furuichi Y: WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet. 152:95–100. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Greenberg RA: Telomeres, crisis and cancer. Curr Mol Med. 5:213–218. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Castro-Vega LJ, Jouravleva K, Liu WY, Martinez C, Gestraud P, Hupe P, Servant N, Albaud B, Gentien D, Gad S, Richard S, Bacchetti S and Londono-Vallejo A: Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas. Carcinogenesis. 34:1173–1180. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ishikawa F: Telomere crisis, the driving force in cancer cell evolution. Biochem Biophys Res Commun. 230:1–6. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Sugimoto M, Furuichi Y, Ide T and Goto M: Involvement of WRN helicase in immortalization and tumorigenesis by the telomeric crisis pathway (Review). Oncol Lett. 2:609–611. 2011.PubMed/NCBI | |
|
Zhu J, Zhao Y and Wang S: Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell. 1:22–32. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H and Blackburn EH: De novo telomere addition by Tetrahymena telomerase in vitro. EMBO J. 16:866–879. 1997. View Article : Google Scholar : PubMed/NCBI |
